Profitelligence Profitelligence · Filing Ledger Open SYK research →

Form 8-K · Current Report · Filed 2026-05-20

Stryker Announces Retirement of CAO and Appointment of Successor

Stryker Corporation announced on May 20, 2026, the retirement of William E.

Filer
Stryker Corporation SYK · NYSE
Filed
Accession
0001193125-26-232643
CIK
0000310764
Signal
Medium impactHealthcare

Details

Berry, Jr., its current Vice President and Chief Accounting Officer, effective September 1, 2026. Emily Baculik, currently Vice President, Corporate Controller, will succeed him as Chief Accounting Officer on the same date. Mr. Berry will serve as an advisor to the Chief Financial Officer until August 15, 2027, under a transition agreement. Ms. Baculik's compensation will be adjusted with an increased base salary and a bonus target, along with potential long-term incentive awards.

Items reported

Item events

Reported Item

CAO Resignation New CAO Appointed

Market reaction

Close before filing

$317.75

Next session

-1.3%

Since filing

+2.5%

Latest close

$325.70

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from SYK reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, SYK insiders reported 31 Form 4 transactions — net selling of $101.8M.

Full SYK insider history →

About Stryker Corporation

Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.

Exchange NYSE Industry Medical Devices Company website ↗

Never miss another SYK filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts